Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice-Reference-Cited by-同舟云学术

Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice

Published:2002-03-22 Issue:3 Volume:446 Page:257-266
ISSN:0021-9967
Container-title:The Journal of Comparative Neurology
language:en
Short-container-title:J. Comp. Neurol.

Author:

Bian Feng,Nath Rathna,Sobocinski Gregg,Booher Robert N.,Lipinski William J.,Callahan Michael J.,Pack Amy,Wang Kevin K.-W.,Walker Lary C.

Publisher

Wiley

Subject

General Neuroscience

Reference70 articles.

1. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5

2. Structure and novel exons of the human .tau. gene

3. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease

4. 1980. The evolution of structural changes in distal axonopathies. In: editors. Experimental and clinical neurotoxicology. Baltimore: Williams and Wilkins. p 179-192.

5. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK5 as a therapeutic tool for the treatment of Alzheimer's disease: A review;European Journal of Pharmacology;2024-09

2. Calcium (Ca²⁺) hemostasis, mitochondria, autophagy, and mitophagy contribute to Alzheimer's disease as early moderators;Cell Biochemistry and Function;2024-07

3. Ubiquitin ligase activity inhibits Cdk5 to control axon termination;PLOS Genetics;2022-04-14

4. Modifications of physical and functional integrity of the blood-brain barrier in an inducible mouse model of neurodegeneration;Neuropharmacology;2021-06

5. Axonopathy Likely Initiates Neuropathological Processes Via a Mechanism of Axonal Leakage in Alzheimer's Mouse Models;Current Molecular Medicine;2019-06-10